Hancock Jaffe Laboratories, Inc. logo
Hancock Jaffe Laboratories, Inc. HJLI

Hancock Jaffe Laboratories, Inc. Financial Ratios 2011-2026 | HJLI

Annual Financial Ratios Hancock Jaffe Laboratories, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-875.0 -1.3 -1.3 - - - - - - -

P/S

1879.8 307.7 90.3 - - - - - - -

EV/EBITDA

90.3 -1.2 -1.9 - - - - - - -

PEG

8.76 0.02 -0.01 - - - - - - -

P/B

1.1 9.7 8.3 - - - - - - -

P/CF

-1.0 -1.5 -2.6 - - - - - - -

ROE %

-0.13 -770.29 -640.47 - - - - - - -

ROA %

-86.69 -222.04 -366.43 - - - - - - -

ROCE %

-124.26 -454.88 -370.02 - - - - - - -

DSO

- - 62.7 - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Hancock Jaffe Laboratories, Inc., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Viemed Healthcare Viemed Healthcare
VMD
$ 9.06 1.23 % $ 347 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 38.78 -1.25 % $ 5.78 K usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.15 4.22 % $ 585 M israelIsrael
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 9.69 3.09 % $ 1.31 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.15 4.01 % $ 155 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 43.13 -0.43 % $ 1.34 B usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 29.17 -2.21 % $ 1.34 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.31 4.42 % $ 115 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Electromed Electromed
ELMD
$ 24.26 1.17 % $ 205 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.53 0.68 % $ 54.5 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
FONAR Corporation FONAR Corporation
FONR
$ 18.51 0.05 % $ 121 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.79 -1.24 % $ 43 M usaUSA
Align Technology Align Technology
ALGN
$ 183.14 0.27 % $ 13.7 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 3.99 7.7 % $ 845 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 113.59 0.01 % $ 198 B usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 13.58 -0.18 % $ 878 M israelIsrael
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 72.75 -1.49 % $ 108 B usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 105.22 0.89 % $ 1.33 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.42 -0.7 % $ 22.9 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.31 16.67 % $ 1.4 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 13.05 0.23 % $ 1.96 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.46 -4.58 % $ 57.1 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Medtronic PLC Medtronic PLC
MDT
$ 95.96 -0.8 % $ 123 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 85.73 0.55 % $ 50.1 B usaUSA